Global Insulin Delivery Devices Market | Asia Pacific is the fastest growing region at the rate of 7.9%
Insulin Delivery Devices Market Report | Global Industry Outlook, Analysis and Forecast 2013-2020
(EMAILWIRE.COM, January 18, 2018 ) The global insulin delivery devices market is expected to reach USD 14.2 billion by 2020 at a CAGR of 6.9% during the forecast period. On the basis of types, insulin delivery devices market has been segmented into insulin syringe, insulin pump, insulin pen, insulin jet injectors, and others. Insulin syringe segment has had the largest market share of global insulin delivery devices in 2016, registering $3.5 billion revenue or the year. The Insulin pumps segment is anticipated to grow at the highest CAGR of 7.5% during the forecast period.
Browse details of our research report on Global Insulin Delivery Devices Market @ https://www.researchcosmos.com/reports/insulin-delivery-devices-market-report-global-industry-outlook-analysis-and-forecast-2013-2020/687240295
Globally, insulin delivery device is witnessing growth primarily due to increase in the prevalence of diabetes. The rise in the geriatric population, growing awareness of diabetes and technological advancement in the delivery device are also driving the growth of the market. In addition, risk factors for Type 2 diabetes and high blood pressure are increasing steadily with the rise in obesity. However, the high cost of insulin and the risks associated with delivery devices are inhibiting the growth of the market.
On the basis of geography, the market has been subdivided into North America, Europe, Asia, and Rest of the World. North America commanded the largest market share of around 43% in 2015, while Asian region is expected to register the fastest growing CAGR of 7.3% during the forecast period.
Key Players
The leading market players in the global insulin delivery devices market include are Novo Nordisk A/S (Denmark), Eli Lily and Company (U.S.), Medtronic, Inc. (Ireland), Becton, Dickinson and Company (U.S.), Sanofi (France), and F. Hoffmann-La Roche. (Switzerland).
Study Objectives
To provide insights about factors influencing and affecting the market growth
To provide historical and forecast revenue of the regional markets and their key countries with respect to market segments
To provide historical and forecast revenue of the market segmented on the basis of products, and applications
To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
Avail Sample Market Brochure of the report for more information, Get a Copy @ https://www.researchcosmos.com/request/687240295
Target Audience
Medical Devices Manufacturers
Medical Devices Distributors
Pharmaceutical companies
Hospitals & Clinics
Service Suppliers
Potential Investors
Key executive (CEO and COO) and strategy growth manager
Key Findings
North America dominated the global market, and was valued at USD 4.6 billion in 2016. It is expected to reach USD 6.0 billion by 2020
Insulin pump will be the fastest growing application segment growing at a CAGR of 7.5% from 2016 to 2020
Europe market was valued at USD 3.3 billion in 2016, and is expected to reach USD 4.4 billion by 2020.
The reports also cover country level analysis:
North America: US, Canada
Europe: Germany, France, U.K., Italy, Spain and Rest of Europe
Asia: China, Japan, India and Rest of Asia
Rest of the World (RoW)
Got some questions, reach us for an enquiry @ https://www.researchcosmos.com/inquire/687240295
About Us:
Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on the gamut of sectors across the globe. Were associated with world-renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.
Contact Us:
Dani Rodriguez
Research Cosmos
+1 888 709 8757
dani@researchcosmos.com
Browse details of our research report on Global Insulin Delivery Devices Market @ https://www.researchcosmos.com/reports/insulin-delivery-devices-market-report-global-industry-outlook-analysis-and-forecast-2013-2020/687240295
Globally, insulin delivery device is witnessing growth primarily due to increase in the prevalence of diabetes. The rise in the geriatric population, growing awareness of diabetes and technological advancement in the delivery device are also driving the growth of the market. In addition, risk factors for Type 2 diabetes and high blood pressure are increasing steadily with the rise in obesity. However, the high cost of insulin and the risks associated with delivery devices are inhibiting the growth of the market.
On the basis of geography, the market has been subdivided into North America, Europe, Asia, and Rest of the World. North America commanded the largest market share of around 43% in 2015, while Asian region is expected to register the fastest growing CAGR of 7.3% during the forecast period.
Key Players
The leading market players in the global insulin delivery devices market include are Novo Nordisk A/S (Denmark), Eli Lily and Company (U.S.), Medtronic, Inc. (Ireland), Becton, Dickinson and Company (U.S.), Sanofi (France), and F. Hoffmann-La Roche. (Switzerland).
Study Objectives
To provide insights about factors influencing and affecting the market growth
To provide historical and forecast revenue of the regional markets and their key countries with respect to market segments
To provide historical and forecast revenue of the market segmented on the basis of products, and applications
To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
Avail Sample Market Brochure of the report for more information, Get a Copy @ https://www.researchcosmos.com/request/687240295
Target Audience
Medical Devices Manufacturers
Medical Devices Distributors
Pharmaceutical companies
Hospitals & Clinics
Service Suppliers
Potential Investors
Key executive (CEO and COO) and strategy growth manager
Key Findings
North America dominated the global market, and was valued at USD 4.6 billion in 2016. It is expected to reach USD 6.0 billion by 2020
Insulin pump will be the fastest growing application segment growing at a CAGR of 7.5% from 2016 to 2020
Europe market was valued at USD 3.3 billion in 2016, and is expected to reach USD 4.4 billion by 2020.
The reports also cover country level analysis:
North America: US, Canada
Europe: Germany, France, U.K., Italy, Spain and Rest of Europe
Asia: China, Japan, India and Rest of Asia
Rest of the World (RoW)
Got some questions, reach us for an enquiry @ https://www.researchcosmos.com/inquire/687240295
About Us:
Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on the gamut of sectors across the globe. Were associated with world-renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.
Contact Us:
Dani Rodriguez
Research Cosmos
+1 888 709 8757
dani@researchcosmos.com
Contact Information:
Research Cosmos
Dani
Tel: +1 888 709 8757
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Research Cosmos
Dani
Tel: +1 888 709 8757
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results